ATC codes: L01DC01
Hodgkin lymphoma ICD11 code: 2C10.Z
Parenteral > General injections > unspecified: 15 mg in vial (as sulfate)
Also recommended for children
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for bleomycin on the complementary list of the EML and EMLc for use in treatment protocols for Hodgkin lymphoma was specifically endorsed. The relevant extracts from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for Hodgkin lymphoma in adults and in paediatrics are attached.